Methylene blue has been advocated for multiple indications, but data reporting its use on intoxication is rare. Acquired methemoglobinemia can be caused by a wide variety of chemicals and toxins and on severe cases, with high methemoglobin levels (>20%), methylene blue is the first line treatment. We describe a case report of a 45-year-old man with acute methemoglobinemia due to involuntary exposure to n-propyl nitrate. The patient came into the emergency department conscious, with profound peripheral and central cyanosis and oxygen saturation of 88% on air, with no response to oxygen supplementation. Arterial blood gas showed methemoglobin of 22.9%. Methylene blue was administered intravenously and symptoms improved dramatically, with control arterial blood gas with 2.6% of methemoglobin. Despite the rarity of occurrence of methemoglobinemia in occupational set, and since methylene blue is highly effective, a high degree of suspicious and good training aiming for prompt diagnosis is crucial in treating this emergency situation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.